Most not long ago, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds into a big selection of endogenous opioids. Not like most opioid receptors, this receptor acts being a scavenger and would not activate a n… Read More